Document:

EX-10.1

 Exhibit 10.1 
  

 
 EMPLOYMENT AGREEMENT 

This Employment Agreement (hereinafter the “Agreement”) is made as of August 1, 2018, by and between David Price, who
currently resides at 7305 Harps Mill Road, Raleigh, NC 27615 (“Employee”) and EyePoint Pharmaceuticals, Inc. (formerly pSivida, Inc. and hereinafter together with its parent, subsidiary, and related or affiliated entities referred
to as the “Company”), having its headquarters at 480 Pleasant Street, Suite B 300, Watertown, Massachusetts 02472 (collectively the “Parties”). 

Recitals 
 WHEREAS, the
Employee desires to be employed by and the Company desires to employ Employee as its Chief Financial Officer; and 
 WHEREAS, the Company
and Employee desire to set forth sets forth the terms and conditions under which the Company agrees to employ Employee and Employee agrees to be employed by the Company; 

Agreement 
 NOW,
THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Company and the Employee
hereby agree as follows: 
 1. Position and Duties. 

(a) Employee will commence employment on August 1, 2018 or such other date as the Company and Employee may agree (the “Start
Date”) on a full-time basis, as the Chief Financial Officer, reporting to the President and Chief Executive Officer of the Company. This is an exempt position. 

(b) Employee agrees to perform the duties of Employee’s position and such other duties as may reasonably be assigned to Employee
consistent therewith from time to time. Employee also agrees that, while employed by the Company, Employee will devote Employee’s full business time and best efforts, business judgment, skill and knowledge exclusively to the advancement of the
business interests of the Company and to the discharge of all assigned duties and responsibilities for them. 

 (c) Employee agrees that, while employed by the Company, Employee will comply with all
Company policies, practices and procedures and all codes of ethics or business conduct applicable to Employee’s position, as in effect from time to time. 

2. Compensation and Benefits. During Employee’s employment, as compensation for all services performed by
Employee for the Company and its subsidiaries and subject to Employee’s full performance of Employee’s obligations hereunder, the Company will provide Employee the following pay and benefits: 

(a) Base Salary. The Company will pay Employee a base salary at the rate of $425,000.00 (Four-Hundred Twenty-Five Thousand Dollars and
Zero Cents) per year, payable in accordance with the regular payroll practices of the Company (as may be adjusted, from time to time, the “Base Salary”). 

(b) Bonus Compensation. For each fiscal year completed during Employee’s employment under this Agreement, Employee will be
eligible for an annual cash bonus. Employee’s target bonus will be 40% of the Base Salary (the “Target Bonus”), with the actual amount of any such bonus being determined by the Board of Directors of the Company (the
“Board”) in its sole discretion, based on Employee’s performance and that of the Company against goals established by the Board and consistent with any applicable plan or program documents and generally applicable Company
policies. Except as otherwise expressly provided in Section 4 hereof, Employee must be employed through the date a bonus is paid in order to earn the bonus. If Employee’s employment terminates, for any reason, prior to payout of the bonus,
the bonus is not earned. 
 (c) Participation in Employee Benefit Plans. Employee will be entitled to participate in all employee
benefit plans from time to time in effect for employees of the Company generally, except to the extent such plans are duplicative of benefits otherwise provided Employee under this Agreement (e.g., a severance pay plan). Employee’s
participation will be subject to the terms of the applicable plan documents and generally applicable Company policies, as the same may be in effect from time to time, and any other restrictions or limitations imposed by law. 

(d) Vacations. Employee will be entitled to twenty (20) of vacation per year, in addition to holidays observed by the Company.
Vacation will accrue monthly on a pro-rated basis. Vacation may be taken at such times and intervals as Employee shall determine, subject to the business needs of the Company. Vacation shall otherwise be
subject to the policies of the Company, as in effect from time to time. 
 (e) Business Expenses. The Company will pay or reimburse
Employee for all reasonable business expenses incurred or paid by Employee in the performance of Employee’s duties and responsibilities for the Company, subject to any maximum annual limit and other restrictions on such expenses set by the
Company and to such reasonable substantiation and documentation as may be specified from time to time. Employee’s right to payment or reimbursement for business expenses hereunder shall be subject to the following additional rules: (i) the
amount of expenses eligible for payment or reimbursement during any calendar year shall not affect the expenses eligible for payment or reimbursement in any other calendar year, (ii) payment or reimbursement shall be made not later than
December 31 of the calendar year following the calendar year in which the expense or payment was incurred, and (iii) the right to payment or reimbursement is not subject to liquidation or exchange for any other benefit. 

  
 2 

 3. Termination of Employment. Employee’s employment under
this Agreement shall continue until terminated pursuant to this Section 3. 
 (a) By the Company for Cause. The Company may
terminate Employee’s employment for Cause upon notice to Employee setting forth in reasonable detail the nature of the Cause. The following, as determined by the Board in its reasonable, good faith judgment, shall constitute
“Cause” for termination: (i) material or willful failure to perform duties reasonably expected and/or requested of Employee (other than by reason of disability) if not cured within 30 days of written notice of such failure;
(ii) material breach of this Agreement or any other agreement between Employee and the Company, including but not limited to any Confidential Information, Non-Disclosure,
Non-Solicitation, Non-Compete, and Rights to Intellectual Property Agreement if not cured within 30 days of written notice of such breach; (iii) commission of, or
plea of nolo contendere to, a felony or other crime involving moral turpitude; (iv) commission of fraudulent or illegal act in commission of Employee’s duties or otherwise with respect to the Company; (v) failure to adhere to moral
and ethical business principles consistent with the Company’s Code of Business Conduct and/or policies in effect from time to time; (vi) engaging in an act or series of acts constituting misconduct resulting in a misstatement of the
Company’s financial statements due to material non-compliance with any financial reporting requirement within the meaning of Section 304 of the Sarbanes-Oxley Act of 2002; or (vii) other conduct
that is or could reasonably be expected to be harmful to the interests or reputation of the Company. 
 (b) By the Company Without
Cause. The Company may terminate Employee’s employment at any time other than for Cause upon two weeks’ notice to Employee. 

(c) By Employee for Good Cause. Employee may terminate Employee’s employment for Good Cause by (A) providing notice to the
Company specifying in reasonable detail the condition giving rise to the Good Cause no later than the thirtieth (30th) day following Employee’s first becoming aware of such event or condition; (B) providing the Company a period of
(30) days to remedy the event or condition; and (C) written notice terminating Employee’s employment for Good Cause within fifteen (15) days following the expiration of the period to remedy if the Company fails to remedy the
condition. The following, if occurring without Employee’s consent, shall constitute “Good Cause” for termination by Employee: (i) a material diminution in the nature or scope of Employee’s position, duties, or
authority (other than temporarily while Employee is physically or mentally incapacitated to such a degree that Employee would be eligible for disability benefits under the Company’s disability income plan or as required by applicable law); (ii)
a material reduction in the Base Salary or the Target Bonus percentage; (iii) a material breach by the Company of this Agreement; (iv) a requirement by the Company that Employee relocate to a location more than thirty (30) miles from
Watertown, Massachusetts. 

  
 3 

 (d) By Employee Without Good Cause. Employee may terminate Employee’s employment
at any time without Good Cause upon thirty (30) days’ notice to the Company. The Board may elect to waive such notice period or any portion thereof; but in that event, the Company shall pay Employee the Base Salary for that portion of the
notice period so waived. 
 (e) Death and Disability. Employee’s employment hereunder shall automatically terminate in the event
of Employee’s death during employment. In the event Employee becomes disabled during employment and, as a result, is unable to continue to perform substantially all of Employee’s duties and responsibilities under this Agreement, either
with or without reasonable accommodation, the Company will continue to pay Employee the Base Salary and to provide Employee benefits in accordance with Section 2(c) above, to the extent permitted by plan terms, for up to twelve (12) weeks
of disability during any period of three hundred sixty-five (365) consecutive calendar days. 
 4. Other Matters Related to
Termination. 
 (a) Final Compensation. In the event of termination of Employee’s employment with the Company, howsoever
occurring, the Company shall pay Employee (i) the Base Salary for the final payroll period of Employee’s employment, pro-rated through the date that Employee’s employment terminates;
(ii) compensation at the rate of the Base Salary for any accrued, unused vacation time; and (iii) reimbursement, in accordance with Section 2(e) hereof, for business expenses incurred by Employee but not yet paid to Employee as of the
date Employee’s employment terminates; provided Employee submits all expenses and supporting documentation required within sixty (60) days of the date Employee’s employment terminates, and provided further that such expenses are
reimbursable under Company policies as then in effect (all of the foregoing, “Final Compensation”). Except as otherwise provided in Section 5(a)(iii), Final Compensation will be paid to Employee within thirty (30) days
following the date of termination (or such shorter period required by law). 
 (b) Severance Payments. In the event of any
termination of Employee’s employment pursuant to Section 3(b) or Section 3(c) above, the Company will pay Employee, in addition to Final Compensation, (i) the Base Salary for the period of twelve (12) months from the date of
termination, provided, however, that if such termination occurs within twelve (12) months following the Start Date (a “Year One Termination”), the Company will instead pay Employee, in addition to Final Compensation, the Base
Salary for the period of six (6) months from the date of termination; (ii) one times the Target Bonus, or 0.5 times the Target Bonus in the event of a Year One Termination, in either case, payable in equal installments during the period of
Base Salary continuation under clause (i). Provided Employee timely elects continuation coverage for Employee and Employee’s eligible dependents under the federal law known as “COBRA” or similar state law, the Company will pay the
monthly amount that equals the portion of the monthly health premiums paid by the Company on Employee’s behalf and that of Employee’s eligible dependents immediately preceding the date that Employee’s employment terminates until the
earlier of (A) the last day of the period of Base Salary continuation under clause (i) and (B) the date that Employee and Employee’s eligible dependents become ineligible for COBRA coverage to the extent permissible by law and plan
terms. The severance payments described in clauses (i) through (iii) above are referred to as the “Severance Payments”. Upon a Change of Control, any options to purchase Stock or shares of restricted Stock held by Employee that
are not fully vested at the time of the Change of Control shall immediately accelerate and vest in full, provided that Employee is employed by the Company on the date of the Change in Control. 

  
 4 

 (c) Conditions to and Timing of Severance Payments. Any obligation of the Company to
provide Employee the Severance Payments and the Equity Acceleration is conditioned, however, on Employee’s cooperation in the transition of Employee’s duties and Employee’s execution and return to the Company of a Severance Agreement
and General Release acceptable to the Company which shall include a release of all claims against the Company, all affiliated and related entities, and/or persons deemed necessary by the Company. The Release may also include Confidentiality, Non-Disparagement, No-Reapply, Tax Indemnification, and/or other appropriate terms. Except as otherwise provided by this Agreement, any Severance Payments to which Employee is
entitled will be provided in the form of salary continuation, payable in accordance with the normal payroll practices of the Company. Unless otherwise provided by this Agreement, the first payment will be made on the Company’s next regular
payday following the effective date of the Severance Agreement and General Release; but that first payment shall include all amounts accrued retroactive to the day following the date Employee’s employment terminated. 

(d) Benefits Termination. Except as provided in Section 4(b) above or under COBRA, Employee’s participation in all employee
benefit plans shall terminate in accordance with the terms of the applicable benefit plans based on the date of termination of Employee’s employment, without regard to any continuation of the Base Salary or other payment to Employee following
termination and Employee shall not be eligible to earn vacation or other paid time off following the termination of Employee’s employment. 

(e) Assistance in Litigation. Employee agrees to reasonably cooperate with the Company in the defense or prosecution of any claims or
actions that relate to events or occurrences that transpired while Employee is or was employed by the Company. Employee’s cooperation includes, but is not limited to, being available to meet with counsel to prepare for discovery or trial and to
act as a witness on behalf of the Company as requested at mutually convenient times. Employee’s cooperation also includes fully cooperating with the Company in connection with any investigation or review by any federal, state, or local
regulatory authority as any such investigation or review relates to events or occurrences that transpired while Employee is or was employed by the Company. 

(f) Survival. Provisions of this Agreement shall survive any termination of employment if so provided in this Agreement or if necessary
or desirable to accomplish the purposes of other surviving provisions, including without limitation Employee’s obligations under Section 4. The obligation of the Company to make payments to Employee under Section 4, are expressly
conditioned upon continued full performance of Employee’s obligations under Section 4 hereof. Upon termination by either Employer or the Company, all rights, duties and obligations of Employee and the Company to each other shall cease,
except as otherwise expressly provided in this Agreement. 

  
 5 

 5. Timing of Payments and Section 409A. 

(a) Notwithstanding anything to the contrary in this Agreement, if at the time Employee’s employment terminates, Employee is a
“specified employee,” as defined below, any and all amounts payable under this Agreement on account of such separation from service that would (but for this provision) be payable within six (6) months following the date of
termination, shall instead be paid on the next business day following the expiration of such six (6) month period or, if earlier, upon Employee’s death; except (A) to the extent of amounts that do not constitute a deferral of
compensation within the meaning of Treasury regulation Section l.409A-1(b) (including without limitation by reason of a short-term deferral or the safe harbor set forth in Section l.409A-l(b)(9)(iii), as
determined by the Company in its reasonable good faith discretion); (B) benefits which qualify as excepted welfare benefits pursuant to Treasury regulation Section l.409A-l(a)(5); or (C) other amounts or benefits that are not subject to the
requirements of, or satisfy an exception from treatment as deferred compensation under, Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”). For purposes of this Agreement, all references to
“termination of employment” and correlative phrases shall be construed to require a “separation from service” (as defined in Section l.409A-l(h) of the Treasury regulations after giving
effect to the presumptions contained therein), and the term “specified employee” means an individual determined by the Company to be a specified employee under Treasury regulation Section
l.409A-l(i). 
 (b) Each payment made under this Agreement shall be treated as a separate payment
and the right to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments. 
 (c)
In no event shall the Company have any liability relating to the failure or alleged failure of any payment or benefit under this Agreement to comply with, or be exempt from, the requirements of Section 409A. 

6. Definitions. For purposes of this Agreement, the following definitions apply: 

“Change of Control” means 

(a) The acquisition by any Person (defined for purposes of this definition as any individual, entity or group (within the meaning of Section
13(d)(3) or Section 14(d)(2) of the Securities Exchange Act of 1934, as amended (“Exchange Act”))) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 35% or more of the common stock of
the Company; provided, however, that for purposes of this subsection (A), an acquisition shall not constitute a Change of Control if it is: (i) either by or directly from the Company, or by an entity controlled by the Company, (ii) by any employee
benefit plan, including any related trust, sponsored or maintained by the Company or an entity controlled by the Company (“Benefit Plan”), or (iii) by an entity pursuant to a transaction that complies with clauses (i), (ii) and (iii) of
subsection (b) below; or Individuals who, as of the effective date of this Agreement, constitute the Board (together with the individuals identified in the proviso to this subsection (B), the “Incumbent Board”) cease for any reason to
constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this agreement whose election, or nomination for election by the Company’s stockholders, was approved by
at least a majority of the directors then comprising the Incumbent Board shall be treated as a member of the Incumbent Board unless he or she assumed office as a result of an actual or threatened election contest with respect to the election or
removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or 

  
 6 

 (b) Consummation of a reorganization, merger or consolidation involving the Company, or a
sale or other disposition of all or substantially all of the assets of the Company (a “Transaction”), in each case unless, following such Transaction, (i) all or substantially all of the Persons who were the beneficial owners of the
common stock of the Company outstanding immediately prior to such Transaction beneficially own, directly or indirectly, more than 50% of the combined voting power of the then outstanding voting securities of the entity resulting from such
Transaction (including, without limitation, an entity that as a result of such Transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same
proportions as their ownership, immediately prior to such Transaction, of the outstanding common stock of the Company, (ii) no Person (excluding any entity or wholly-owned subsidiary of any entity resulting from such Transaction or any Benefit
Plan of the Company or such entity or wholly-owned subsidiary of such entity resulting from such Transaction) beneficially owns, directly or indirectly, 35% or more of the combined voting power of the then outstanding voting securities of such
entity except to the extent that such ownership existed prior to the transaction and (iii) at least a majority of the members of the board of directors or similar board of the entity resulting from such Transaction were members of the Incumbent
Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Transaction; or 
 (c)
Approval by the stockholders of the Company of a liquidation or dissolution of the Company. 
 “Person” means an
individual, a corporation, a limited liability company, an association, a partnership, an estate, a trust or any other entity or organization, other than the Company or any of its subsidiaries. 

7. Conflicting Agreements. Employee hereby represents and warrants that the signing of this Agreement and the
performance of Employee’s obligations under it will not breach or be in conflict with any other agreement to which Employee is a party or is bound, and that Employee is not subject to any covenants against competition or similar covenants or
any court order that could affect the performance of Employee’s obligations under this Agreement. Employee agrees that Employee will not disclose to or use on behalf of the Company any confidential or proprietary information of a third party
without that party’s consent. 
 8. Withholding. All payments made by the Company under this Agreement
shall be reduced by any tax or other amounts required to be withheld by the Company under applicable law. 
 9.
Assignment. Neither Employee nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without the prior written consent of the other; provided, however,
the Company may assign its rights and obligations under this Agreement without Employee’s consent to one of its subsidiaries or to any Person with whom 

  
 7 

 
the Company shall hereafter effect a reorganization, consolidate or merge, or to whom the Company shall hereafter transfer all or substantially all of its properties or assets. This Agreement
shall inure to the benefit of and be binding upon Employee and the Company, and each of its respective successors, executors, administrators, heirs and permitted assigns. 

10. Severability. If any portion or provision of this Agreement shall to any extent be declared illegal or
unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected
thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 

11. Miscellaneous. This Agreement sets forth the entire agreement between Employee and the Company, and replaces
all prior and contemporaneous communications, agreements and understandings, written or oral, with respect to the terms and conditions of Employee’s employment, other than the Confidential Information,
Non-Disclosure, Non-Solicitation, Non-Compete, and Rights to Intellectual Property Agreement dated July __, 2018, a copy of
which is attached as Exhibit A and incorporated herein by reference. This Agreement may not be modified or amended, and no breach shall be deemed to be waived, unless agreed to in writing by Employee and an expressly authorized representative of the
Board. 
 12. Notice. Any notice required to, or permitted to, be given under this agreement shall be sufficient
if in writing (a) delivered personally, (b) sent by first class certified mail, return receipt requested, postage and fees pre-paid, or (c) sent by prepaid overnight delivery service, to the
Parties at the following addresses (or at such other addresses as shall be specified by the Parties in a like notice); 
  

									
	 If to Company:
	  	 EyePoint Pharmaceuticals, Inc.
 110 Allen
Road
 Second Floor
 Basking Ridge, NJ 07920

Attention: Senior Vice President Human Resources
	  		  		  	
					
	 If to Employee:
	  	 David Price
 7305 Harps Mill Road

Raleigh, NC 27615
	  		  		  	

 All notices shall be deemed to have been given upon receipt if delivered personally, or by recognized
overnight courier, or five (5) days after mailing if mailed. 

  
 8 

 13. Governing Law. This Agreement shall be governed by, and construed
in accordance with, the laws of the State of New Jersey, without regard to its conflicts of law provisions. Any claim arising out of, or relating to this Agreement including, without limitation, any action commenced by the Company for preliminary
and permanent injunctive relief or other equitable relief, shall be instituted in any federal or state court in the State of New Jersey. Each party agrees not to assert by way of motion, as a defense or otherwise, in any such claim, that such party
is not subject personally to the jurisdiction of such court, that the claim is brought in an inconvenient forum, that the venue of the claim is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.
Each party further irrevocably submits to the exclusive jurisdiction of such court in any such claim. 
 Any and all service of process and
any other notice in any such claim shall be effective against any party if given personally or by registered mail, return receipt requested, mailed to such party as provided herein. Nothing herein contained shall be deemed to affect the right of any
party to serve process in any manner permitted by law. 
 14. Usage. All pronouns and any variations thereof shall be
considered to refer to the masculine, feminine or neuter, singular or plural, as the context may require. All terms defined in the Agreement in their singular or plural forms have correlative meanings when used herein in their singular or plural
forms, respectively. Unless otherwise expressly provided the words “include” “includes” and “including” do not limit the preceding words or terms and shall be deemed followed by the words “without limitation.”

 15. Headings. The headings in this Agreement are for reference only, and shall not affect the interpretation of this
Agreement. 
 16. Counterparts. This Agreement may be executed by the parties hereto in separate counterparts, each of
which when so executed and delivered shall be an original, but all such counterparts, together shall constitute one, and the same, instrument. Each counterpart may consist of a number of copies hereof each signed by less than all, but together
signed by all of the parties hereto. 
 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above. 
  

							
		 	EyePoint Pharmaceuticals, Inc.	 		 	
				
	By:	 	 /s/ Nancy Lurker
	 		 	 /s/ David Price

		 	Nancy Lurker	 		 	David Price
		 	President & CEO	 		 	
		 	Date:     8/1/18                    	 		 	Date:     8/1/18                    

  
 9Exhibit

EXHIBIT 10.1

EA Bonus Plan
Addendum

FY19 Bonus Formula

Subject to all other terms and conditions of the EA Bonus Plan (“Plan”)*, those Plan Participants who have been specifically identified by Electronic Arts Inc. (the “Company”) as eligible to receive a discretionary bonus pursuant to the terms of this Addendum shall have such bonus determined as follows:

		
	1.
	Additional Eligibility Criteria, If Any:

n/a (see Plan eligibility criteria)

		
	2.
	Fiscal 2019 Bonus Pool

Funding for a Company-wide bonus pool (“Bonus Pool”) for Fiscal 2019 will be approved by the Compensation Committee (the “Committee”) of the Company’s Board of Directors (the “Board”).
	
				
	Bonus Component(s)
	Weight
	Performance Measure(s)
	Measurement Period(s)

	Company Financial Performance
	50%
	25% Non-GAAP Earnings Per Share and 25% Non-GAAP Net Revenue 
	Fiscal 2019

	Business Performance
	50%
	The achievement of measurable business objectives, including, but not limited to business and operational performance metrics, profit and revenue targets 
	Fiscal 2019

The Company Performance component is funded based on the Company’s performance against Non-GAAP Earnings Per Share and Non-GAAP Net Revenue targets for the Measurement Period. 

The Business Performance component is funded by the Committee upon consideration of measurable business objectives, including, but not limited to, business and operational performance metrics, profit and revenue targets. 

		
	a.
	Allocation of Bonus Pool Funding To Business Units:

Following the completion of the Measurement Period, Company management will allocate, at its discretion, a percentage of the Bonus Pool funding to each business unit.  Such allocation will be based upon the achievement of measurable business unit objectives or such other factors as Company management deems relevant to the business unit’s performance. 

		
	b.
	Individual Bonus Award Payouts:

Annual Bonus Award payouts:  in most circumstances, Annual Bonus Award payouts will be determined based upon an assessment of: 

(1)   The Participant’s target bonus amount; 
(2)   The percentage of the Bonus Pool allocated to a Participant’s business unit (if applicable); and 
(3)   The Participant’s Individual Performance, as determined by the Participant’s manager.  

The Individual Performance assessment takes into account the Participant’s contributions to the Company for the fiscal year relative to individual performance expectations.  

The Committee will review and approve the individual Participant bonus award payouts for the Company’s executive officers under Section 16 of the Securities and Exchange Act, of 1934, other than the CEO.

		
	3.
	Bonus Award for the CEO

	
				
	Bonus Component(s) 
	Weight 
	Performance Measure(s) 
	Measurement Period(s) 

	Financial Performance 
	60% 
	Non-GAAP Net Revenue, Gross Profit, Operating Expenses, Non-GAAP Earnings Per Share, Operating Cash Flow
	Fiscal 2019 

	Strategic & Operational Performance 
	40% 
	The achievement of measurable business objectives, including strategic and operational performance metrics 
	Fiscal 2019

Bonus Award payout: A Bonus Award payout for the CEO will be determined by the Board based upon an overall assessment of the following: 

(1)   The CEO’s target bonus amount; 
(2)   Attainment and weighting of Financial, Strategic and Operational Performance objectives for the Measurement Period; and 
(3)   The Company Bonus Funding.

The Board will approve the CEO Bonus Award after assessing the factors set forth above and has discretion to increase or decrease the final bonus payout based on any such other factors it deems applicable, provided that the final bonus payout shall not exceed the lesser of (1) 300% of the CEO’s target bonus amount for the Measurement Period, and (2) $5 million and no bonus may be paid if the Company’s net income falls below a certain threshold. 

		
	4.
	Payment Schedule:

Bonus Awards will be paid as soon as administratively practicable following the completion of the Measurement Period and the Committee’s approval of the Bonus Pool funding. 

* Including, but not limited to: (1) the Plan Participant must be actually employed by EA or one of its subsidiaries or affiliates on the date that each payment is made pursuant to the Plan in order to earn the right to receive each such payment, (2) except where otherwise required by local law, at any time until the date that bonuses are paid under the Plan, the individual must not have (i) violated any provision of EA's Global Code of Conduct, any other written EA policy and any law, rule or regulation applicable to EA and EA employees, or (ii) entered into an employment termination or separation agreement (not including agreements entered into in connection with the commencement or continuation of employment), and (3) eligibility to receive a bonus calculated pursuant to this Addendum does not guarantee the payment of any bonus for a specific Measurement Period, nor does it guarantee employment for any specific period of time. Capitalized terms in this Addendum shall have the meanings set forth in the Plan, except where such terms are separately defined in this Addendum.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]